Engineered Immune Cells and Targeted Therapies Show Promise in Slowing Early Spread of Triple-Negative Breast Cancer, Study Finds
A groundbreaking preclinical study has introduced a promising paradigm in the fight against triple-negative breast cancer (TNBC), a notoriously aggressive ...
